BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 12373812)

  • 1. [Hemostatic abnormalities in DIC].
    Wada H
    Rinsho Byori; 2002 Aug; 50(8):768-72. PubMed ID: 12373812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of pre-disseminated intravascular coagulation stage with hemostatic molecular markers. The Mie DIC Study Group.
    Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Mori Y; Deguchi K; Shiku H
    Pol J Pharmacol; 1996; 48(2):225-8. PubMed ID: 9112656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
    Koga S
    Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemostatic molecular markers before onset of disseminated intravascular coagulation in leukemic patients.
    Wada H; Sakuragawa N; Shiku H
    Semin Thromb Hemost; 1998; 24(3):293-7. PubMed ID: 9701463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of disseminated intravascular coagulation in relation to the score when treatment was begun. Mie DIC Study Group.
    Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Mori Y; Shiku H
    Thromb Haemost; 1995 Sep; 74(3):848-52. PubMed ID: 8571309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the responses of global tests of coagulation with molecular markers of neutrophil, endothelial, and hemostatic system perturbation in the baboon model of E. colisepsis--toward a distinction between uncompensated overt DIC and compensated non-overt DIC.
    Wada H; Yamamuro M; Inoue A; Shiku H; Sakuragawa N; Redl H; Peer G; Taylor FB
    Thromb Haemost; 2001 Dec; 86(6):1489-94. PubMed ID: 11776318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
    Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
    Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased plasma-soluble fibrin monomer levels in patients with disseminated intravascular coagulation.
    Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Deguchi H; Mori Y; Kaneko T; Deguchi K; Fujii J; Shiku H
    Am J Hematol; 1996 Apr; 51(4):255-60. PubMed ID: 8602623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis of DIC based on evidence].
    Wada H; Nishioka J; Nobori T; Sakaguchi A; Abe Y
    Rinsho Byori; 2006 Nov; 54(11):1172-7. PubMed ID: 17240840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of hemostatic molecular marker].
    Wada H; Ioka M
    Rinsho Byori; 1997 Apr; 45(4):310-4. PubMed ID: 9136593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of plasma soluble fibrin using a new ELISA method in patients with disseminated intravascular coagulation.
    Okajima K; Uchiba M; Murakami K; Okabe H; Takatsuki K
    Am J Hematol; 1996 Mar; 51(3):186-91. PubMed ID: 8619398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.
    Levi M; Toh CH; Thachil J; Watson HG
    Br J Haematol; 2009 Apr; 145(1):24-33. PubMed ID: 19222477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical usefulness of the measurements of plasmin-alpha 2-plasmin inhibitor complex and plasma tissue factor activity in patients with disseminated intravascular coagulation].
    Fukuda C; Iijima K; Nakamura K
    Rinsho Byori; 1996 Aug; 44(8):750-6. PubMed ID: 8816061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum thrombomodulin as a prognostic marker of disseminated intravascular coagulation.
    Kotajima N; Kanda T; Fukumura Y; Kobayashi I
    J Med; 1999; 30(1-2):19-29. PubMed ID: 10515237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application of hemostatic molecular markers for diagnosis of thrombosis].
    Wada H; Sakakura M; Nobori T; Shiku H
    Rinsho Byori; 2000 Apr; 48(4):301-7. PubMed ID: 10810874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disseminated intravascular coagulation (DIC).
    Mammen EF
    Clin Lab Sci; 2000; 13(4):239-45. PubMed ID: 11586511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of DIC in multiple organ failure.
    Kidokoro A; Iba T; Hong J
    Int J Surg Investig; 2000; 2(1):73-80. PubMed ID: 12774341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hemostatic changes before and after the onset of disseminated intravascular coagulation].
    Wada H; Tanigawa M; Takagi M; Suzuki H; Mori Y; Ohta T; Kobayashi T; Kita K; Tanaka I; Yamaguchi T
    Rinsho Ketsueki; 1989 Oct; 30(10):1755-62. PubMed ID: 2593241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Description of compensated and uncompensated disseminated intravascular coagulation (DIC) responses (non-overt and overt DIC) in baboon models of intravenous and intraperitoneal Escherichia coli sepsis and in the human model of endotoxemia: toward a better definition of DIC.
    Taylor FB; Wada H; Kinasewitz G
    Crit Care Med; 2000 Sep; 28(9 Suppl):S12-9. PubMed ID: 11007191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Coagulation tests in septic surgical patients].
    Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
    Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.